Get started
Author

Núria Aguilera

New insights into the genetic etiology of Alzheimer’s disease and related dementias
2022 · Céline Bellenguez, Fahri Küçükali, et al. · Nature Genetics · 2,479
Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project
2019 · Sonia Moreno‐Grau, Itziar de Rojas, et al. · Alzheimer s & Dementia · 163
PDF
Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes
2023 · Yann Le Guen, Guo Luo, et al. · Proceedings of the National Academy of Sciences · 60
Biomarkers of Alzheimer's disease and neurodegeneration in dried blood spots—A new collection method for remote settings
2024 · Hanna Huber, Kaj Blennow, et al. · Alzheimer s & Dementia · 54
PDF
Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer’s type
2022 · Pamela V Martino Adami, Adelina Orellana, et al. · Brain · 49
PDF
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients
2023 · Daniele Altomare, Frederik Barkhof, et al. · JAMA Neurology · 45
PDF
Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic
2024 · Amanda Cano, Maria Capdevila, et al. · EBioMedicine · 44
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
2023 · Xavier Morató, Marta Marquié, et al. · Scientific Reports · 44
PDF
Exploring APOE genotype effects on Alzheimer's disease risk and amyloid β burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results
2017 · Sonia Moreno–Grau, Octavio Rodríguez‐Gómez, et al. · Alzheimer s & Dementia · 41
PDF
Analysis of Psychological Symptoms Following Disclosure of Amyloid–Positron Emission Tomography Imaging Results to Adults With Subjective Cognitive Decline
2023 · Camilla Caprioglio, Federica Ribaldi, et al. · JAMA Network Open · 39
PDF
The role of sex and gender in the selection of Alzheimer patients for clinical trial pre-screening
2021 · Maitee Rosende-Roca, Carla Abdelnour, et al. · Alzheimer s Research & Therapy · 31
PDF
Genome-wide significant risk factors on chromosome 19 and the APOE locus
2018 · Sonia Moreno-Grau, Alzheimer’s Disease Neuroimaging Initiative, et al. · Oncotarget · 27
PDF
The Synergic Effect of AT(N) Profiles and Depression on the Risk of Conversion to Dementia in Patients with Mild Cognitive Impairment
2023 · Marta Marquié, Fernando García-Gutiérrez, et al. · International Journal of Molecular Sciences · 17
PDF
Exploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive Endophenotypes
2018 · Ana Espinosa, Begoña Hernández-Olasagarre, et al. · Frontiers in Aging Neuroscience · 16
PDF
Amyloid deposition in adults with drug‐resistant temporal lobe epilepsy
2024 · Elena Fonseca, Sofía Lallana, et al. · Epilepsia · 14
Macular vessel density in the superficial plexus is not a proxy of cerebrovascular damage in non-demented individuals: data from the NORFACE cohort
2024 · Ainhoa García-Sánchez, Oscar Sotolongo-Grau, et al. · Alzheimer s Research & Therapy · 11
PDF
Macular vessel density in the superficial plexus is not associated to cerebrospinal fluid core biomarkers for Alzheimer’s disease in individuals with mild cognitive impairment: The NORFACE cohort
2023 · Marta Marquié, Ainhoa García-Sánchez, et al. · Frontiers in Neuroscience · 10
Genomic Characterization of Host Factors Related to SARS-CoV-2 Infection in People with Dementia and Control Populations: The GR@ACE/DEGESCO Study
2021 · Itziar de Rojas, Isabel Hernández, et al. · Journal of Personalized Medicine · 9
PDF
Managing Clinical Trials for Alzheimer’s Disease During the COVID-19 Crisis: Experience at Fundació ACE in Barcelona, Spain
2020 · Carla Abdelnour, Ester Esteban de Antonio, et al. · Journal of Alzheimer s Disease · 7
PDF
Safety and equity in scaling minimally invasive surgery worldwide in 109 countries using cholecystectomy as a tracer procedure: a prospective cohort study
2026 · Sivesh K Kamarajah, Omar Kouli, et al. · The Lancet Global Health · 3
Linking genomic and proteomic signatures to brain amyloid burden: insights from GR@ACE/DEGESCO
2025 · Raquel Puerta, Itziar de Rojas, et al. · Functional & Integrative Genomics · 3
Connecting genomic and proteomic signatures of amyloid burden in the brain
2024 · Raquel Puerta, Itziar de Rojas, et al. · medRxiv · 1
PDF
A single-center open-label, randomized, parallel-group controlled clinical trial on the long-term effect of the treatment with EGb 761 in blood markers of inflammation and neurodegeneration in patients with mild cognitive impairment: ACE-2020-EGb 761
2026 · Xavier Morato, Marta Marquié, et al. · Journal of Alzheimer s Disease
Landscape of copy number variants in Spanish people with dementia
2026 · Itziar de Rojas, Pablo García-González, et al. · npj Genomic Medicine
PDF
Can we determine Alzheimer’s disease neuropathology from the finger?
2024 · Hanna Huber, Laia Montoliu‐Gaya, et al. · Alzheimer s & Dementia
PDF
Works count: 48
Citation count: 5,644
H-index: 15
I10-index: 18
Year
Topic
Type